Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD28 antibody variable domain is fused to the C terminal of an IgG of anti-MUC1 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-MUC1 Bispecific Antibody (IgG-Fv) (BSGV-H238). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS